glp-1 small molecule agonist A Small-Molecule Oral of the Human Glucagon-like Peptide-1 Receptor The challenge of developing oral

Importantly, the triagonist also lowered fasting blood glucose levels and improved glucose tolerance without inducing hypoglycemia

Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists

Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

What is Blood Sugar, and Why Does It Matter for Healthy Aging

This work was also supported by the National Key Research and Development Program of China (2018YFA0507001, 2018YFA0507000, 2018YFA0508100), the National Natural Science Foundation of China grants 31770898 (G.S.), 31900895 (L.Y.) and 81872915 (M.-W.W.), the National Science and Technology Major Project Key New Drug Creation and Manufacturing Program of China (2018ZX09735-001) and China Postdoctoral Science Foundation (2017M622365)

Notably, a close relationship has been observed between the S1 protein of SARS-CoV-2 and DPP4, emphasizing the significance of DPP4s tissue distribution in understanding viral interactions